Genes
Oligo Pools
NGS
Variant Libraries
Synthetic Controls
Antibody Discovery
IVDR Solutions
Poster
Webinar
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Synthetic DNA Technologies Enable Fast and Responsive SARS-CoV-2 Antibody Discovery and Optimization
Synthetic DNA Technologies Enable Fast and Responsive SARS-CoV-2 Antibody Discovery and Optimization
Presented by
Aaron Sato
Twist Bioscience
RECORDED AT Writing the Future of Infectious Disease
Covered in this Webinar
Twist Biopharma's panel of highly diverse synthetic naïve antibody phage display libraries,
Several target class specific antibody phage display libraries against difficult-to-drug targets,
A Twist Antibody Optimization (TAO) platform for antibody affinity and developability optimization
Highlighting the power of this platform, our anti-SARS-CoV-2 antibody discovery and optimization efforts are presented.
Utilizing its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody discovery and optimization solutions for the biotechnology industry.
Share your details to Watch the Webinar
